The evaluation of cardiovascular risk in SLE patients Cardiovascular mortality is a major cause of death in SLE patients. Several investigators have convincingly shown that women with SLE under the age of 50 are at substantially increased risk of ischaemic heart disease. Women with SLE aged 35-44 were over 50 times more likely to have a myocardial infarction than women of similar age from a population. Longitudinal studies are required to define optimal preventive strategies for cardiovascular events in SLE.

Studierea manifestărilor cardiovasculare în lupusul eritematos sistemic (LES) – maladie autoimună cu afectare multisistemică, de etiologie necunoscută cu manifestări clinice şi paraclinice variate, asociate cu hiperproducţie de autoanticorpi şi cu un potenţial fatal major, inclusiv prin evenimente cardiovasculare reprezintă un domeniu de interes ştiinţific susţinut şi o problemă cu importante valenţe medico-sociale.